AION Labs is a venture studio dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development. It is a unique partnership formed by AstraZeneca, Merck, Pfizer, Teva, the Israel Biotech Fund, Amiti Ventures, and AWS, with support from BioMed X.
By combining global pharmaceutical expertise with cutting-edge AI and biotechnology, AION Labs' unique venture studio model creates an optimal environment for startups by fostering cross-industry partnerships, funding opportunities, and offering unparalleled access to pharma R&D expertise and data.
Company Details
- Employees
- 23
- Founded
- -
- Address
- Science Park, Rehovot,israel
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aionlabs.com
- Keywords
- (AWS) Israel & Africa.
- HQ
- Rehovot
Aion Labs Questions
Aion Labs's website is http://www.aionlabs.com
Aion Labs's LinkedIn profile is https://il.linkedin.com/company/aion-labs
Aion Labs has
23 employees.
View email and phone details for 23
employees at Aion Labs.
Aion Labs's industry is
Biotechnology Research
Aion Labs's top competitors are
Protai,
Evogene,
Prophet,
Promise Bio,
Denovai Biotech,
Cytoreason,
Biomed X Institute,
Immunai,
Nucleai,
Memed.
Aion Labs's categories are Biotechnology Research
Aion Labs's founding year is 2021
